Drug Information

General Information
Drug ID
DR00181
Drug Name
Panobinostat
Synonyms
(E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE; (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide; Faridak; LBH 589; LBH-589; LBH-589B; LBH589; NVP-LBH-589; NVP-LBH589; Panobinostat, NVP-LBH589, LBH589
Drug Type
Small molecular drug
Indication Multiple myeloma [ICD11: 2A83] Approved [1]
Structure
3D MOL 2D MOL
Formula
C21H23N3O2
Canonical SMILES
CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO
InChI
InChI=1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/b11-10+
InChIKey
FPOHNWQLNRZRFC-ZHACJKMWSA-N
CAS Number
CAS 404950-80-7
Pharmaceutical Properties Molecular Weight 349.4 Topological Polar Surface Area 77.2
Heavy Atom Count 26 Rotatable Bond Count 7
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 3
XLogP
3
PubChem CID
6918837
PubChem SID
103632713 , 109693246 , 114788640 , 118049495 , 12015928 , 123051106 , 124756947 , 125163753 , 126657606 , 126666979 , 126731350 , 127342240 , 127342241 , 131404644 , 131465111 , 134339363 , 134964365 , 135252712 , 136340102 , 136345863 , 136367899 , 136379865 , 136920346 , 137003312 , 140114795 , 143497586 , 144116133 , 152212116 , 152237701 , 152258137 , 152344186 , 15274143 , 160646976 , 162011828 , 162037392 , 162193612 , 163312349 , 164194122 , 164825246 , 17195129 , 172086282 , 43530200 , 57372035 , 62645030 , 75710455 , 81055018 , 87226499 , 87350378 , 93300558 , 99436947
ChEBI ID
CHEBI:85990
TTD Drug ID
D0E3SH
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Panobinostat was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Panobinostat for the treatment of multiple myeloma: the evidence to date. J Blood Med. 2015 Oct 8;6:269-76.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.